Skip to main content
SpringerLink
Log in

Sarcomas of Bone

  • Chapter
  • First Online:
60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center

  • 1177 Accesses

Abstract

Sarcomas of bone are a rare and diverse set of tumors that, although related in their primary location (bone), vary in their etiology, behavior, and treatment. In 2011, approximately 2,890 new cases of bone and joint cancers were diagnosed in the USA. Osteosarcoma, chondrosarcoma, and Ewing sarcoma are the most common primary tumors of bone, representing 30 %, 15 %, and 6 %, respectively, of all bone sarcomas. The remainder of bone sarcomas is made up of malignant fibrous histiocytoma, chordoma, adamantinoma, hemangioendothelioma, hemangiopericytoma, and low-grade fibrosarcoma of the bone.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Giuffrida AY, Burgueno JE, Koniaris LG, Gutierrez JC, Duncan R, Scully SP. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am. 2009;91:1063–72.

    Article  PubMed  Google Scholar 

  2. Smith MA, GJ, Ries LA. Cancer in adolescents 15 to 19 years old. In: Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1997 (NIH Pub. No. 99-4649). Bethesda, MD: National Cancer Institute; 1999.

    Google Scholar 

  3. Stiller CA, Bielack SS, Jundt G, Steliarova-Foucher E. Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2124–35.

    Article  PubMed  CAS  Google Scholar 

  4. Ries LAG, SM, Gurney JG, et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995 (NIH Pub. No. 99-4649). Bethesda, MD: National Cancer Institute; 1999. p. 99–110.

    Google Scholar 

  5. Data from the American Cancer Society. American Cancer Society. http://www.cancer.org/docroot/home/index.asp. Accessed 23 May 2012.

  6. Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009;115:1531–43.

    Article  PubMed  Google Scholar 

  7. Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res. 1986;204:9–24.

    PubMed  Google Scholar 

  8. Benjamin R, Chawla S, Murray J, et al. Preoperative chemotherapy for osteosarcoma: a treatment approach facilitating limb salvage with major prognostic indications. In: Jones S, Salmon S, editors. Adjuvant therapy of cancer IV. Philadelphia: Grune and Stratton; 1984. p. 601–10.

    Google Scholar 

  9. Hudson M, Jaffe MR, Jaffe N, et al. Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experience. J Clin Oncol. 1990;8:1988–97.

    PubMed  CAS  Google Scholar 

  10. Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med. 1986;314:1600–6.

    Article  PubMed  CAS  Google Scholar 

  11. Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol. 1987;5:21–6.

    PubMed  CAS  Google Scholar 

  12. Rosen G, Nirenberg A. Neoadjuvant chemotherapy for osteogenic sarcoma: a five year follow-up (T-10) and preliminary report of new studies (T-12). Prog Clin Biol Res. 1985;201:39–51.

    PubMed  CAS  Google Scholar 

  13. Mavligit GM, Calvo 3rd DB, Patt YZ, Hersh EM. Immune restoration and/or augmentation of local xenogeneic graft versus host reaction by Cimetidine in vitro. J Immunol. 1981;126:2272–4.

    PubMed  CAS  Google Scholar 

  14. Stewart DJ, Benjamin RS, Zimmerman S, et al. Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II). Cancer Res. 1983;43:917–20.

    PubMed  CAS  Google Scholar 

  15. Jaffe N, Raymond AK, Ayala A, et al. Effect of cumulative courses of intraarterial cis-diamminedichloroplatin-II on the primary tumor in osteosarcoma. Cancer. 1989;63:63–7.

    Article  PubMed  CAS  Google Scholar 

  16. Jaffe N, Robertson R, Ayala A, et al. Comparison of intra-arterial cis-diamminedichloroplatinum II with high-dose methotrexate and citrovorum factor rescue in the treatment of primary osteosarcoma. J Clin Oncol. 1985;3:1101–4.

    PubMed  CAS  Google Scholar 

  17. Bacci G, Ferrari S, Donati D, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremity in patients in the fourth and fifth decade of life. Oncol Rep. 1998;5:1259–63.

    PubMed  CAS  Google Scholar 

  18. Jaffe N, Carrasco H, Raymond K, Ayala A, Eftekhari F. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? Cancer. 2002;95:2202–10.

    Article  PubMed  Google Scholar 

  19. Peabody TD, Gibbs Jr CP, Simon MA. Evaluation and staging of musculoskeletal neoplasms. J Bone Joint Surg Am. 1998;80:1204–18.

    PubMed  CAS  Google Scholar 

  20. Link M, Meyers P, Gebhardt M. Osteosarcoma. In: Pizzo P, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott, Williams, & Wilkins; 2006. p. 1074–115.

    Google Scholar 

  21. Meyers PA, Schwartz CL, Krailo MD, et al. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival – a report from the Children’s Oncology Group. J Clin Oncol. 2008;26:633–8.

    Article  PubMed  CAS  Google Scholar 

  22. Glass AG, Fraumeni Jr JF. Epidemiology of bone cancer in children. J Natl Cancer Inst. 1970;44:187–99.

    PubMed  CAS  Google Scholar 

  23. Fraumeni Jr JF, Glass AG. Rarity of Ewing’s sarcoma among U.S. Negro children. Lancet. 1970;1:366–7.

    Article  PubMed  Google Scholar 

  24. Parkin DM, Stiller CA, Nectoux J. International variations in the incidence of childhood bone tumours. Int J Cancer. 1993;53:371–6.

    Article  PubMed  CAS  Google Scholar 

  25. Jawad MU, Cheung MC, Min ES, Schneiderbauer MM, Koniaris LG, Scully SP. Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973-2005. Cancer. 2009;115:3526–36.

    Article  PubMed  Google Scholar 

  26. Bacci G, Ferrari S, Bertoni F, et al. Prognostic factors in nonmetastatic Ewing’s sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol. 2000;18:4–11.

    PubMed  CAS  Google Scholar 

  27. Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group. J Clin Oncol. 2000;18:3108–14.

    PubMed  CAS  Google Scholar 

  28. Nesbit Jr ME, Gehan EA, Burgert Jr EO, et al. Multimodal therapy for the management of primary, nonmetastatic Ewing’s sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol. 1990;8:1664–74.

    PubMed  Google Scholar 

  29. Burgert Jr EO, Nesbit ME, Garnsey LA, et al. Multimodal therapy for the management of nonpelvic, localized Ewing’s sarcoma of bone: intergroup study IESS-II. J Clin Oncol. 1990;8:1514–24.

    PubMed  Google Scholar 

  30. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348:694–701.

    Article  PubMed  CAS  Google Scholar 

  31. Ferrari S, Mercuri M, Rosito P, et al. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing’s sarcoma of the extremity. J Chemother. 1998;10:484–91.

    PubMed  CAS  Google Scholar 

  32. Kolb EA, Kushner BH, Gorlick R, et al. Long-term event-free survival after intensive chemotherapy for Ewing’s family of tumors in children and young adults. J Clin Oncol. 2003;21:3423–30.

    Article  PubMed  CAS  Google Scholar 

  33. Gibbs CP, Weber KL, Scarborough MT. Malignant bone tumors. In: Beaty JH, editor. AAOS instructional course lectures, vol. 51. Rosemont: American Academy of Orthopaedic Surgeons; 2002. p. 413–28.

    Google Scholar 

  34. Bacci G, Toni A, Avella M, et al. Long-term results in 144 localized Ewing’s sarcoma patients treated with combined therapy. Cancer. 1989;63:1477–86.

    Article  PubMed  CAS  Google Scholar 

  35. Wilkins RM, Pritchard DJ, Burgert Jr EO, Unni KK. Ewing’s sarcoma of bone. Experience with 140 patients. Cancer. 1986;58:2551–5.

    Article  PubMed  CAS  Google Scholar 

  36. Horowitz ME, Neff JR, Kun LE. Ewing’s sarcoma. Radiotherapy versus surgery for local control. Pediatr Clin North Am. 1991;38:365–80.

    PubMed  CAS  Google Scholar 

  37. Bacci G, Forni C, Longhi A, et al. Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution. J Surg Oncol. 2007;96:118–23.

    Article  PubMed  Google Scholar 

  38. Wittig JC, Bickels J, Kellar-Graney KL, Kim FH, Malawer MM. Osteosarcoma of the proximal humerus: long-term results with limb-sparing surgery. Clin Orthop Relat Res. 2002;156–76

    Google Scholar 

  39. Lindner NJ, Ramm O, Hillmann A, et al. Limb salvage and outcome of osteosarcoma. The University of Muenster experience. Clin Orthop Relat Res. 1999;83–9

    Google Scholar 

  40. Picci P, Sangiorgi L, Rougraff BT, Neff JR, Casadei R, Campanacci M. Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol. 1994;12:2699–705.

    PubMed  CAS  Google Scholar 

  41. Rougraff BT, Simon MA, Kneisl JS, Greenberg DB, Mankin HJ. Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg Am. 1994;76:649–56.

    PubMed  CAS  Google Scholar 

  42. Nagarajan R, Clohisy DR, Neglia JP, et al. Function and quality-of-life of survivors of pelvic and lower extremity osteosarcoma and Ewing’s sarcoma: the Childhood Cancer Survivor Study. Br J Cancer. 2004;91:1858–65.

    Article  PubMed  CAS  Google Scholar 

  43. Barr RD, Wunder JS. Bone and soft tissue sarcomas are often curable–but at what cost?: a call to arms (and legs). Cancer. 2009;115:4046–54.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler St., Unit 1448, Houston, TX, 77030, USA

    Valerae Lewis

Authors
  1. Valerae Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Valerae Lewis .

Editor information

Editors and Affiliations

  1. Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, 77030, Texas, USA

    M. Alma Rodriguez

  2. Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, 77030, Texas, USA

    Ronald S. Walters

  3. Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, 77030, Texas, USA

    Thomas W. Burke

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lewis, V. (2013). Sarcomas of Bone. In: Rodriguez, M., Walters, R., Burke, T. (eds) 60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5197-6_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-5197-6_28

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-5196-9

  • Online ISBN: 978-1-4614-5197-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation